The human iPSC cell line, CARS-FiPS4F1 (ESi064-A), derived from dermal fibroblast from the apparently healthy carrier of the mutation of the gene SACSIN, was generated by non-integrative reprogramming technology using OCT3/4, SOX2, CMYC and KLF4 reprogramming factors. The pluripotency was assessed by immunocytochemistry and RT-PCR. This iPSC line can be used as control for Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) disease.

Institute of Experimental Medicine Department of Tissue Cultures and Stem Cells Academy of Science of the Czech Republic Prague Czech Republic

National Stem Cell Bank Valencian Node Platform for Proteomics Genotyping and Cell Lines PRB3 Research Centre Principe Felipe c Eduardo Primo Yufera 3 46012 Valencia Spain

Servicio de Neuropediatría Hospital Universitario La Paz Madrid Spain

Stem Cells Therapies in Neurodegenerative Diseases Lab Centro de Investigacion Principe Felipe Valencia Spain

Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders and Service of Genomics and Translational Genetics Centro de Investigación Príncipe Felipe Valencia Spain

000      

00000naa a2200000 a 4500

001      

bmc19034927

003      

CZ-PrNML

005      

20191015120648.0

007      

ta

008      

191007s2018 enk f 000 0|eng||

009      

AR

024    7_

$a 10.1016/j.scr.2018.10.016 $2 doi

035    __

$a (PubMed)30384130

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a enk

100    1_

$a Machuca, Candela $u Stem Cells Therapies in Neurodegenerative Diseases Lab, Centro de Investigacion Principe Felipe (CIPF), Valencia, Spain; Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders and Service of Genomics and Translational Genetics, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain.

245    10

$a Generation of human induced pluripotent stem cell (iPSC) line from an unaffected female carrier of mutation in SACSIN gene / $c C. Machuca, A. Vilches, E. Clemente, SI. Pascual-Pascual, A. Bolinches-Amorós, A. Artero Castro, C. Espinos, M. Leon, P. Jendelova, S. Erceg,

520    9_

$a The human iPSC cell line, CARS-FiPS4F1 (ESi064-A), derived from dermal fibroblast from the apparently healthy carrier of the mutation of the gene SACSIN, was generated by non-integrative reprogramming technology using OCT3/4, SOX2, CMYC and KLF4 reprogramming factors. The pluripotency was assessed by immunocytochemistry and RT-PCR. This iPSC line can be used as control for Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) disease.

650    _2

$a dospělí $7 D000328

650    _2

$a ženské pohlaví $7 D005260

650    _2

$a proteiny tepelného šoku $x genetika $7 D006360

650    _2

$a lidé $7 D006801

650    _2

$a indukované pluripotentní kmenové buňky $x metabolismus $7 D057026

650    _2

$a mutace $7 D009154

655    _2

$a kazuistiky $7 D002363

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Vilches, Angel $u Stem Cells Therapies in Neurodegenerative Diseases Lab, Centro de Investigacion Principe Felipe (CIPF), Valencia, Spain.

700    1_

$a Clemente, Eleonora $u Stem Cells Therapies in Neurodegenerative Diseases Lab, Centro de Investigacion Principe Felipe (CIPF), Valencia, Spain.

700    1_

$a Pascual-Pascual, Samuel Ignacio $u Servicio de Neuropediatría, Hospital Universitario La Paz, Madrid, Spain.

700    1_

$a Bolinches-Amorós, Arantxa $u National Stem Cell Bank-Valencian Node, Platform for Proteomics, Genotyping and Cell Lines PRB3, Research Centre Principe Felipe, c/Eduardo Primo Yufera 3, 46012, Valencia, Spain.

700    1_

$a Artero Castro, Ana $u National Stem Cell Bank-Valencian Node, Platform for Proteomics, Genotyping and Cell Lines PRB3, Research Centre Principe Felipe, c/Eduardo Primo Yufera 3, 46012, Valencia, Spain.

700    1_

$a Espinos, Carmen $u Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders and Service of Genomics and Translational Genetics, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain.

700    1_

$a Leon, Marian $u National Stem Cell Bank-Valencian Node, Platform for Proteomics, Genotyping and Cell Lines PRB3, Research Centre Principe Felipe, c/Eduardo Primo Yufera 3, 46012, Valencia, Spain.

700    1_

$a Jendelova, Pavla $u Institute of Experimental Medicine, Department of Tissue Cultures and Stem Cells, Academy of Science of the Czech Republic, Prague, Czech Republic.

700    1_

$a Erceg, Slaven $u Stem Cells Therapies in Neurodegenerative Diseases Lab, Centro de Investigacion Principe Felipe (CIPF), Valencia, Spain; National Stem Cell Bank-Valencian Node, Platform for Proteomics, Genotyping and Cell Lines PRB3, Research Centre Principe Felipe, c/Eduardo Primo Yufera 3, 46012, Valencia, Spain; Institute of Experimental Medicine, Department of Tissue Cultures and Stem Cells, Academy of Science of the Czech Republic, Prague, Czech Republic. Electronic address: serceg@cipf.es.

773    0_

$w MED00167579 $t Stem cell research $x 1876-7753 $g Roč. 33, č. - (2018), s. 166-170

856    41

$u https://pubmed.ncbi.nlm.nih.gov/30384130 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20191007 $b ABA008

991    __

$a 20191015121114 $b ABA008

999    __

$a ok $b bmc $g 1451587 $s 1073477

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2018 $b 33 $c - $d 166-170 $e 20181012 $i 1876-7753 $m Stem cell research $n Stem Cell Res $x MED00167579

LZP    __

$a Pubmed-20191007